Skip to content
Bayesian Scientific Work Group
  • Home
  • Subteams
    • Use of historical data/prior specification
    • Joint Modeling
    • Program-wide Decision Making
    • Missing Data
    • Education
    • Pediatrics and Small Population Drug Development
    • Medicine Adaptive Pathway to Patients (MAPPs)
    • Benefit-Risk
    • Non-inferiority
    • Reporting/Tools
    • Medical Outreach
    • Safety
    • Best Practice
    • NonClinical
    • Real World Evidence
    • Adaptive Design Survey
    • COVID-19
  • Resources
    • KOL Lecture Series
    • Books and Papers
    • Presentations
    • Case Studies and Newsletters
    • Software
    • DIA BSWG KOL Lecture Series, L29
  • Events
  • About Us
  • Contact Us

Presentations


Substantial Evidence in 21st Century Regulatory Science

2016-DIA BSWG Face-to-Face Meeting

European Medicines Agency: EMA Paediatric Medicines Office and PDCO Enpr-EMA

2017 F2F Meeting Slides

2018-DIA-BSWG-F2F-Agenda

2018-DIA-BSWG-F2F-Updates

2018-DIA-BSWG-F2F-ADSWG_Collaboration

2018-DIA-BSWG-F2F-Hist_Data_Discussion

2019 F2F Meeting Agenda

2022 DIA BSWG F2F-Agenda

2022 DIA BSWG F2F-Overview by Freda Cooner

2022 DIA BSWG F2F: COVID19 Subteam Update by Estelle Russek-Cohen

2022 DIA BSWG F2F-IDSWG update by Sammi Tang

2022 DIA BSWG F2F-Bayesian Thinking A Personal View Motivated by COVID by Steve Ruberg

2022 DIA BSWG F2F-A Bayesian Group-sequential Design for COVID-19 Vaccine Development by Satrajit Roychoudhury

Bayesian Work Group

  • Home
  • Workstreams/Subgroups
  • About Us
  • Events
  • Contact Us
  • Log In